Projections of the costs associated with colorectal cancer care in the United States, 2000-2020
- PMID: 17910108
- DOI: 10.1002/hec.1307
Projections of the costs associated with colorectal cancer care in the United States, 2000-2020
Abstract
Because of aging trends in the US, the number of prevalent colorectal cancer patients is expected to increase. We projected economic burden to the Medicare program and its beneficiaries through the year 2020. Burden was estimated for the initial phase of care, the period following diagnosis, the last year of life, and the continuing phase. Projected burden was evaluated with varying assumptions about incidence, survival, and costs of care. Estimated costs of care in 2000 in the initial, continuing, and last year of life phases of care were approximately $3.18 billion, $1.68 billion, and $2.63 billion, respectively. By the year 2020 under the 'fixed' current incidence, survival, and cost scenario, projected costs for the initial, continuing, and last year of life phases were $4.75 billion, $2.63 billion, and $4.05 billion. Under the current trends scenario (decreasing incidence, improving survival, and increasing costs), costs were $5.19 billion, $3.57 billion, and $5.27 billion. By the year 2020, estimated costs of colorectal cancer care among individuals aged 65 and older increased by 53% in the fixed scenario and by 89% in the current trends scenario. The future economic burden of colorectal cancer to the Medicare program and its beneficiaries in the US will be substantial.
Published in 2007 by John Wiley & Sons, Ltd.
Similar articles
-
Cost of care for elderly cancer patients in the United States.J Natl Cancer Inst. 2008 May 7;100(9):630-41. doi: 10.1093/jnci/djn103. Epub 2008 Apr 29. J Natl Cancer Inst. 2008. PMID: 18445825
-
Projecting the number of patients with colorectal carcinoma by phases of care in the US: 2000-2020.Cancer Causes Control. 2006 Dec;17(10):1215-26. doi: 10.1007/s10552-006-0072-0. Cancer Causes Control. 2006. PMID: 17111252
-
Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.Med Care. 2009 Jul;47(7 Suppl 1):S56-63. doi: 10.1097/MLR.0b013e3181a4f482. Med Care. 2009. PMID: 19536010
-
Economic costs of diabetes in the U.S. In 2007.Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017. Diabetes Care. 2008. PMID: 18308683 Review.
-
Measuring costs: administrative claims data, clinical trials, and beyond.Med Care. 2002 Jun;40(6 Suppl):III63-72. Med Care. 2002. PMID: 12064760 Review.
Cited by
-
Medical Costs and Healthcare Utilization among Cancer Decedents in the Last Year of Life in 2009.Cancer Res Treat. 2016 Jan;48(1):365-75. doi: 10.4143/crt.2014.088. Epub 2015 Mar 2. Cancer Res Treat. 2016. PMID: 25761472 Free PMC article.
-
Cancer prevalence in United States, Nordic Countries, Italy, Australia, and France: an analysis of geographic variability.Br J Cancer. 2013 Jul 9;109(1):219-28. doi: 10.1038/bjc.2013.311. Epub 2013 Jun 25. Br J Cancer. 2013. PMID: 23799856 Free PMC article.
-
Promoting physical activity through supervised vs motivational behavior change interventions in breast cancer survivors on aromatase inhibitors (PAC-WOMAN): protocol for a 3-arm pragmatic randomized controlled trial.BMC Cancer. 2023 Jul 5;23(1):632. doi: 10.1186/s12885-023-11137-1. BMC Cancer. 2023. PMID: 37407950 Free PMC article.
-
Years of Life and Productivity Loss from Potentially Avoidable Colorectal Cancer Deaths in U.S. Counties with Lower Educational Attainment (2008-2012).Cancer Epidemiol Biomarkers Prev. 2017 May;26(5):736-742. doi: 10.1158/1055-9965.EPI-16-0702. Epub 2016 Dec 21. Cancer Epidemiol Biomarkers Prev. 2017. PMID: 28003180 Free PMC article.
-
Cost of benign versus oncologic colon resection among fee-for-service Medicare enrollees.J Surg Oncol. 2019 Aug;120(2):280-286. doi: 10.1002/jso.25511. Epub 2019 May 27. J Surg Oncol. 2019. PMID: 31134661 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical